cancer
Highlights From the 2025 Gut Microbiota For Health World Summit
The 2025 Gut Microbiota for Health World Summit featured cutting-edge research on microbiome science and medicine, ...
AUGUST 15, 2025
Are New Treatments on the Horizon for Pancreatic Cancer?
In this first episode of The Scope, host David Robbins, MD, interviews Nicholas Hornstein, MD, PhD, about new ...
APRIL 29, 2025
Gastric Metaplasia Confers High Risk For Cancer in Study of Mostly White Patients
Patients with gastric intestinal metaplasia had a 19-fold higher risk of developing gastric cancer than those who ...
DECEMBER 9, 2024
Vyloy With Chemotherapy Approved for Gastric or Gastroesophageal Junction Adenocarcinoma
The FDA has approved zolbetuximab for the first-line treatment of adults with advanced gastric or gastroesophageal ...
NOVEMBER 4, 2024
Expert Picks From EASL 2024
Ashwani K. Singal, MD, MS, highlights four abstracts from EASL Congress 2024.
OCTOBER 30, 2024
BE Indefinite for Dysplasia Requires Close Follow-up in Year After Diagnosis
Management of Barrett’s esophagus patients who have tissue that is indefinite for dysplasia hasn’t ...
OCTOBER 23, 2024
New ACG Guideline on Managing Focal Liver Lesions
The American College of Gastroenterology recently released a new clinical guideline on focal liver lesions.
OCTOBER 17, 2024
FDA Approves Next-Gen mt-sDNA test, Cologuard Plus
The FDA has approved the next-generation of the multitarget stool DNA test Cologuard (Exact Sciences).
OCTOBER 9, 2024
New-Onset Diabetes Is an Early Clue to Pancreatic Cancer
New-onset diabetes in adults older than 50 years of age could be a manifestation of pancreatic cancer, according to ...
SEPTEMBER 12, 2024
Latest Updates on Esophageal Fluorescence-Guided Surgery
Esophageal fluorescence-guided surgery has rapidly gained ground.
SEPTEMBER 12, 2024
FDA Approves LONSURF With Bevacizumab for Previously Treated mCRC
The FDA approved trifluridine and tipiracil (LONSURF, Taiho Oncology) with bevacizumab, for previously treated ...
AUGUST 26, 2024
FIT Reduces Deaths From Colorectal Cancer
Evidence is emerging for the power of fecal immunochemical testing to not only reduce colorectal cancer incidence ...
AUGUST 13, 2024
